The five: robots helping to tackle coronavirus

The UN has equipped Rwanda with five anti-epidemic robots made by Belgian company Zora Bots to help against the country’s battle with coronavirus. The robots can screen a patient’s temperature, identify people not wearing masks and monitor abnormalities in how patients sound or look. They can also be used to deliver medicine and other essentials to the infected.

Read full article here. 

Drug innovation is back in fashion

The pandemic has reminded the world of the industry’s strengths—its capacity to innovate and provide drugs on a vast scale. Many of the big firms, such as Johnson & Johnson and Sanofi, are working on covid-19 vaccines and therapies. Scores of smaller companies are at work, too. On May 18th Moderna, an American biotech firm, said that its much-anticipated vaccine has shown positive early results (although some analysts questioned the validity of its tests). AstraZeneca, a big British firm that invests heavily in research and development (r&d), is working on a vaccine with scientists at Oxford University, helped by $1bn of new funding from America’s government. Even before the virus, the industry had started to invest more heavily. In the most recent quarter America’s 30 biggest firms boosted their r&d by a median of 6% year on year. Now medical innovation is back in fashion.

Read full article here.

Beyond telehealth: the virtual care technology trends that will transform healthcare

A recent estimate by consulting firm McKinsey suggests that $250 billion in healthcare spending could shift to virtual care models in the wake of the COVID-19 pandemic.

Notwithstanding the dramatic headline, there is no disputing that we are directionally headed towards a significant shift in the way care is delivered. If anything, the actual shift in spend could be much higher.

Read full article here.

The planet's health is our health: why healthcare must go green

The need to connect the health of people with the planet’s health is the key to driving more sustainable solutions for healthcare, given the vast cost to our well-being of air, water and soil pollution, as reflected by an estimated 9 million premature deaths globally.

By supporting healthy environments, we contribute to a healthier ecosystem and could slow – even prevent – the incidence of disease on a global scale.

Read full article here.

A flood of coronavirus apps are tracking us. Now it’s time to keep track of them

As the covid-19 pandemic rages, technologists everywhere have been rushing to build apps, services, and systems for contact tracing: identifying and notifying all those who come in contact with a carrier. Some are lightweight and temporary, while others are pervasive and invasive: China’s system, for example, sucks up data including citizens’ identity, location, and even online payment history so that local police can watch for those who break quarantine rules.
Read full article here.